ArticleFrontiers in immunology2021

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.

Xin Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.